Thomas Trimarchi
BridgeBio (United States)(US)Bridge Pharma (United States)(US)New York University(US)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Epigenetics and DNA Methylation, Acute Lymphoblastic Leukemia research, RNA modifications and cancer, Cancer-related gene regulation
Most-Cited Works
- → Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia(2012)525 cited
- → Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia(2014)413 cited
- → A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia(2011)379 cited
- → Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia(2014)370 cited
- → The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability(2013)370 cited
- → Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo(2013)320 cited
- → The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia